ChemoCentryx Reaches Analyst Target Price
February 20, 2020 at 09:07 AM EST
In recent trading, shares of ChemoCentryx, Inc. (CCXI) have crossed above the average analyst 12-month target price of $49.33, changing hands for $50.52/share..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|